Navigation Links
Linc Facility Services Acquires Morse Medical
Date:2/5/2008

WASHINGTON, Feb. 5 /PRNewswire/ -- Linc Facility Services(R), LLC and its family of companies today announced it has acquired Morse Medical, Inc., the largest independent clinical technology maintenance and management service organization in the Pacific Northwest. The acquisition is part of an aggressive growth strategy by Linc to strengthen its healthcare service portfolio, and accelerate the expansion of its geographic footprint.

Headquartered in Bellevue, Washington, Morse Medical has 10 service centers across the Puget Sound. Its comprehensive services span everything from basic field service for physician offices to complete turnkey solutions for hospital and health care systems. The company's founder and president, Wayne Morse, brings more than 35 years experience to the company and is one of only 15 people nationwide named as Fellows in the American College of Clinical Engineering (ACCE).

"Morse Medical's talented executives and team of employees have built a company with a long-standing reputation for innovation and quality service that fits perfectly into our operation," said Phil Rogers, president of Linc Facility Services. "Their complementary capabilities will add yet another layer of expertise and leadership to our existing Technology in Medicine healthcare practice. And, the transaction will broaden our reach on the West Coast, as well as expand the range of medical equipment services we offer medical facilities."

Morse Medical will merge into Technology in Medicine, LLC, but will continue to do business as Morse Medical. The company will be branded as "A Linc Facility Services Company" and become an integral part of the commercial division.

"Morse Medical brings exceptional commitment to detail and customer satisfaction that complements Linc's world-class business infrastructure and quality management," said Wayne Morse, founder and president of Morse Medical. "Together, we can take our service offerings to the next
'/>"/>

SOURCE Linc Facility Services, LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Energy Conversion Devices and United Solar Ovonic Enter Into New $55 Million Secured Credit Facility Agreements
2. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
3. Medical University of South Carolina Opens State-of-the-Art Facility
4. Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology
5. Protalix BioTherapeutics Signs Lease Agreement for Expansion of its Manufacturing and Research Facility in Carmiel, Israel
6. Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility
7. China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility
8. Science Teachers Tour Ventrias Bioprocessing Facility
9. BioEnergy International Facility Opens in Bay State
10. Dendreon Secures $130 Million Committed Equity Financing Facility
11. Tandem Labs New England Facility Doubles Discovery Support Capacity - Increasing Foothold in New England
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Inc. (NYSE: IMA ), a global leader in ... through the merger of rapid diagnostics and health management, has ... B Convertible Perpetual Preferred Stock ( IMA-PB). The dividend will ... amount per share equal to the quotient of (a) $3.00 ...
(Date:12/2/2009)... Corporation (Nasdaq: MATK ) announced today that it intends ... year 2009 on December 16, 2009, at approximately 4:00 p.m. ... ET Martek will conduct a conference call to discuss these ... the call live via webcast by visiting Martek,s web site ...
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com announces ... available in its catalogue: ,, Carbondioxide ... ,, http://www.reportlinker.com/p0164368/Carbondioxide-Incubators---A-Global-Market-Perspective.html ,, Incubators ... microbiology, genetics, cancer, research, and other applications ...
(Date:12/2/2009)... concept demonstration tires made with BioIsoprene technology, ... in the manufacture of synthetic rubber with renewable biomass, ... tire will be on display at a lounge in ... throughout December 21, while the other tire will make ...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3
... NV (Euronext,Brussels: THR), a biotechnology company focused on ... financial results for the seven month,period ending 30 ... funds to invest in its development pipeline and ... programs. Highlights - Successful placing of ...
... Aug. 24 AGA Medical Corporation ("AGA"),announced today ... Administration,(FDA) and European CE Mark approvals for the ... AMPLATZER Vascular Plug II expands the AGA family ... vessel and blood vessel,malformations in the peripheral vasculature. ...
... announced today the,release of two major upgrades to ... multilaser capability and the Beta release of a ... well beyond,conventional optical limitations. The Multilaser upgrade ... additional lasers including a 405nm (violet) laser and ...
Other Biology Technology:ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 2ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 3ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 4ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 5ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 6ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 7ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 8ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 9ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 10ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 11AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II 2Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System 2
(Date:12/4/2009)... activity in organs relevant for coronary artery disease (CAD), ... identified a module of genes that is important for ... plaque. The findings, which are to be published in ... targeting the migration of white blood cells in the ...
(Date:12/4/2009)... Using a new mathematical model of heart cells, University ... critical enzyme, calmodulin kinase II (CaM kinase), disrupts the ... study, which also involved Columbia University, was published online ... . , "Recently, researchers have developed great interest ...
(Date:12/3/2009)... new information and adapt to changes in our daily environment, ... in the minute junctions where nerve cells communicate, according to ... study is published online this week in the journal ... PhD, associate professor of physiology and neuroscience at NYU School ...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2U-Iowa study helps advance heart-related research 2Lifelong memories linked to stable nerve connections 2Global Bioenergies is Setting Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Rene 14455 1Global Bioenergies is Setting Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Rene 14455 2The Alpha 1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics Inc 14451 1The Alpha 1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics Inc 14451 2The Alpha 1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics Inc 14451 3The Alpha 1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics Inc 14451 4FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets 5446 1FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets 5446 2FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets 5446 3
... The way aquatic plants respond to plant disease ... land-based agriculture, say plant pathologists with The American ... III, Cornell University, Ithaca, NY, many aquatic plants ... "Through further study, plant pathologists may be able ...
... virus infiltrates human cells to cause encephalitis. Designated as ... Agenda, the virus exploits a protein essential to embryonic ... online edition of Nature reports the findings July 6. ... be used as a potential bioterrorism agent capable of ...
... blood disease, primarily affecting males, where the blood ... one in 6000 Australian males is born with ... with haemophilia rely on intravenous infusion of recombinant ... and her Harvard colleagues have made ground-breaking discoveries ...
Other Biology News:UCLA scientists reveal how Nipah virus infects cells 2Promising therapies for haemophilia & heart disease 2
... The x2 Dual-Binary Analytical System more ... binary LC and LC/MS. The fast analysis ... increased by up to 100% in tandem ... the multi-dimensional mode. Using backflush or heartcut ...
... weight of 16 kDa. Leptin is a protein ... [1,2]. Leptin is thought to play a key ... In the human, leptin levels are elevated with increasing ... relationship between serum leptin levels and several measures of ...
... random mutations to the gene supplied by a ... a vector of choice to obtain a library ... be set to a desired value within 1-20 ... Mutations can be restricted to a desired ...
Request Info...
Biology Products: